Troleandomycin

  • TRADE NAME: TAO (Pfizer)
  • INDICATIONS: Various infections caused by susceptible organisms
  • CLASS: Antibiotic, macrolide
  • HALF-LIFE: N/A

Our database has 9 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
MUCOSAL
CARDIOVASCULAR
NEUROMUSCULAR/SKELETAL
GASTROINTESTINAL/HEPATIC


Page last updated 09/19/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric